ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Market Movers(Regular)

View all
NasdaqNYSEAMEXOTCTSXEuronextLSE

NASDAQ Market Status

Advancing
2,378(59.76%)
Declining
1,580(39.71%)
Unchanged
21(0.53%)
  • % Gainers
  • % Losers
  • Most Active
TickerNamePriceChangeChange %Volume
AVTX LogoAVTXAvalo Therapeutics Inc21.1216.37344.63%21,938,581
XLO LogoXLOXilio Therapeutics Inc1.450.811126.92%28,761,117
CERO LogoCEROCERo Therapeutics Holdings Inc2.88011.2576.69%16,492,087
BDRX LogoBDRXBiodexa Pharmaceuticals PLC1.510.65175.79%82,318,243
KYCH LogoKYCHKeyarch Acquisition Corporation11.74014.7367.59%160,513
MESO LogoMESOMesoblast Limited5.04961.5644.69%12,000,783
NTRB LogoNTRBNutriband Inc5.851.8044.44%366,569
NXL LogoNXLNexalin Technologies Inc1.110.3342.31%2,370,817
IMNN LogoIMNNImunon Inc1.92010.520137.15%1,039,441
PEGR LogoPEGRProject Energy Reimagined Acquisition Corporation11.502.8432.79%48,026
PIK LogoPIKKidpik Corporation4.321.0532.11%9,035,186
BOLD LogoBOLDBoundless Bio Inc14.70-45.27-75.49%500,873
PMEC LogoPMECPrimech Holdings Ltd1.3999-2.48-63.92%6,091,310
NBSTW LogoNBSTWNewbury Street Acquisition Corporation0.042279-0.02622-38.28%1,750
GMDA LogoGMDAGamida Cell Ltd0.0377-0.0215-36.32%66,309,622
TNXP LogoTNXPTonix Pharmaceuticals Holding Corporation0.224-0.1029-31.48%15,250,528
KOD LogoKODKodiak Sciences Inc5.51-1.94-26.04%1,680,222
NDRA LogoNDRAENDRA Life Sciences Inc0.609-0.2113-25.76%507,750
UGRO LogoUGROUrban Gro Inc1.37-0.445-24.52%467,202
DTST LogoDTSTData Storage Corporation5.93-1.71-22.38%661,969
AWIN LogoAWINAERWINS Technologies Inc0.058-0.0164-22.04%2,009,855
AKBA LogoAKBAAkebia Therapeutics Inc1.81-0.43-19.20%49,255,177
NKLA LogoNKLANikola Corporation1.040.130914.40%131,245,486
BDRX LogoBDRXBiodexa Pharmaceuticals PLC1.510.65175.79%82,318,243
MARA LogoMARAMarathon Digital Holdings Inc22.930.863.90%67,300,531
GMDA LogoGMDAGamida Cell Ltd0.0377-0.0215-36.32%66,309,622
AKAN LogoAKANAkanda Corporation0.1593-0.0056-3.40%64,882,660
CISS LogoCISSC3is Inc0.0343-0.0039-10.21%54,250,940
TSLA LogoTSLATesla Inc176.905-2.93-1.63%51,965,320
AKBA LogoAKBAAkebia Therapeutics Inc1.81-0.43-19.20%49,255,177
SQQQ LogoSQQQProShares UltraPro Short QQQ10.4710.0710.68%48,373,907
AMD LogoAMDAdvanced Micro Devices Inc180.89831.310.73%40,401,681
TLRY LogoTLRYTilray Brands Inc2.4757-0.0043-0.17%38,900,316
TradesView all

Big Movers

11:00
Business Wire

Gilead Sciences, Inc. (Nasdaq: GILD) and Xilio Therapeutics, Inc. (Nasdaq: XLO) today announced an exclusive license agreement to develop and commercialize Xilio’s Phase 1 tumor-activated IL-12 program, XTX301.

12:30
PR Newswire (US)

SINGAPORE, March 28, 2024 /PRNewswire/ -- Primech Holdings Limited (Nasdaq: PMEC) ("Primech" or the "Company"), an established technology-driven facilities services provider in the public and private sectors operating mainly in Singapore, provides a financial and corporate update coincident with the filing of the Company's financial results for the six months ended September 30, 2023. These financial results are for periods prior to the Company's initial public offering ("IPO") in October of 2023.

12:02
Business Wire

Kidpik Corp. (NASDAQ: PIK) ("kidpik” or the "Company"), an online clothing subscription-based e-commerce company, today announced that the Company received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that is has regained full compliance with the Minimum Bid Price Requirement.

10:30
PR Newswire (US)

Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection points  New Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy actively recruiting  Phase 1b study of KSI-101 planned for 2Q2024 with the goal of initiating dual pivotal studies in 2024  New Phase 3 DAYBREAK study in wet AMD to include KSI-501 and tarcocimab investigational groups versus aflibercept targeted to start recruitment mid-2024 following completion of FDA discussions  Investor day to be scheduled after on-going regulatory interactions completedPALO ALTO, Calif., March 28, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and ...

Ticker Buzz Cloud
What is the Buzz Cloud?
  • The Buzz Cloud keeps track of how often tickers are mentioned to indicate the "level of buzz".
  • The larger the text, the more often the ticker is mentioned by the community.
  • You can use this page to spot trading opportunities based on the increase or decrease in the level of buzz.

Unlock more advanced trading tools

Join ADVFN today

Top Cryptocurrencies

View All Cryptos
Crypto Market Status
Advancing
8971(34%)
Declining
2918(11%)
Unchanged
14459(55%)
Ticker Name Price Change Change % Market Cap Volume
BTCBitcoin70,802.031,337.461.93%1.39T5,924,400,454
ETHEthereum3,552.8752.811.51%426.42B3,011,796,586
USDTTether USD0.999930.000490.05%97.83B778,178,608
BNBBinance Coin582.218.091.41%91.74B420,462,148
SOLSolana185.39-0.730-0.39%81.58B1,299,865,812
STETHstETH3,535.8071.372.06%34.62B5,686,979
XRPRipple0.63340.02193.58%34.33B470,233,109
DOGEDogecoin0.220070.0300315.80%31.4B2,737,450,589
USDCUSD Coin1.000.000.00%28.07B1,323,830,752
ADACardano0.65060.0030.46%22.85B153,952,924

Economic Calendar

This week's major US economic reports, Fed Speakers, indicators and market-moving events.
View full calendar